Form 4 for HQL abrdn Life Sciences Investors
Accepted 2025-02-13 00:00:00 ET · period of report 2025-02-12 · accession 0001510281-25-000090 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-02-13 | 2025-02-12 | HQL | Weinstein Boaz | 10% | S - Sale | $13.75 | -36.5K | 3.28M | -1% | -$502.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-12 | S | D | 36,536 | $13.75 | 3,276,181 | I - | — | — |